Pasar al contenido principal

MODELADO Y SIMULACION DE LA MEDICINA DE PRECISION EN CARDIOLOGIA

PID2022-140553OB-C41

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

In silico systematic evaluation of the scar effect in conventional and new cardiac resynchronization therapy approaches

  • Ruiz, Cristóbal Rubén
  • Gómez, Juan F.
  • Osca, Joaquín
  • Izquierdo, Maite
  • Mora-Fenoll, María Teresa|||0000-0002-8069-2486
  • Trenor Gomis, Beatriz Ana|||0000-0001-9166-6112
[EN] Objective: Cardiac resynchronization therapy (CRT) is a technique used in the clinical setting to solve dyssynchronization problems in ventricular contraction. The goal of this study was to evaluate in silico the performance of conventional and new CRT approaches under left bundle branch block (LBBB) and heart failure (HF) conditions, and especially under myocardial scar presence. Methods: The simulations were run in a 3D realistic biventricular model including the His-Purkinje system, where the different pathologies were modeled. Stimulation protocols corresponding to each of the CRT approaches assessed were applied. Importantly, the presence of infarcted tissue was systematically evaluated according to the American Heart Association segmentation of the heart. To assess CRT performance, a set of six biomarkers obtained from simulated ECG signals and activation maps was defined. Results: Our simulations showed that under LBBB and HF conditions with or without infarction scar, the newer CRT approaches performed better. Interestingly, the inclusion of scarred tissue in some basal and septal segments had detrimental effects on the biomarkers that particularly worsened when Purkinje fibers were considered as non-conductive. Conclusions: This study sheds light on the effects that several heart disruptions have in cardiac activation before and after traditional and newest CRT methods. Moreover, the utilization of fusion pacing and Purkinje fibers survivability post-infarction, has demonstrated an improvement in the overall outcome of CRT. Significance: In silico models could constitute a powerful tool to understand, evaluate, and optimize different CRT approaches, which could help clinicians to plan personalized CRT procedures and reduce patient's risk., This work was supported by Grant PID2019-104356RB-C41 funded by MCIN/AEI/10.13039/501100011033, by Grants PID2022-136273OA-C33 and PID2022-140553OB-C41 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU, and by the European Union's Horizon 2020 research and innovation program under grant agreement No 101016496 (SimCardioTest) . The authors also thankfully acknowledge the computer resources at MareNostrum (IM-2021-1-0001, IM-2021-1-0003, IM-2022-1-0002, IM-2023-1-0002) and MareNostrum5 (IM-2024-1-0010 and IM-2024-2-0015) and the technical support provided by Barcelona Supercomputing Center.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Datos de investigación Set de datos (Dataset)

Experimentally Validated Modeling of Dynamic Drug-hERG Channel Interactions Reproducing the Binding Mechanisms and its Importance in Action Potential Duration

  • Escobar-Ropero, Fernando|||0000-0001-7602-447X
  • Gomis-Tena Dolz, Julio|||0000-0002-1309-2368
  • Saiz Rodríguez, Francisco Javier|||0000-0002-9850-0825
  • Romero Pérez, Lucia|||0000-0003-4605-8630
  • Friis, Soren
  • Adly, Nouran
  • Brinkwirth, Nina
  • Arne Klaerke, Dan
  • Stoelzle-Feix, Sonja
Background and Objective: Assessment of drug cardiotoxicity is critical in the development of new compounds and modeling of drug-binding dynamics to hERG can improve early cardiotoxicity assessment. We previously developed a methodology to generate Markovian models reproducing preferential state-dependent binding properties, trapping dynamics and the onset of IKr block using simple voltage clamp protocols. Here, we test this methodology with real IKr blockers and investigate the impact of drug dynamics on action potential prolongation. Methods: Experiments were performed on HEK cells stably transfected with hERG and using the Nanion SyncroPatch 384i. Three protocols, P-80, P0 and P40, were applied to obtain the experimental data from the drugs and the Markovian models were generated using our pipeline. The corresponding static models were also generated and a modified version of the O´Hara-Rudy action potential model was used to simulate the action potential duration. Results: The experimental Hill plots and the onset of IKr block of ten compounds were obtained using our voltage clamp protocols and the models generated successfully mimicked these experimental data, unlike the CiPA dynamic models. Marked differences in APD prolongation were observed when drug effects were simulated using the dynamic models and the static models. Conclusions: These new dynamic models of ten well-known IKr blockers constitute a validation of our methodology to model dynamic drug–hERG channel interactions and highlight the importance of state-dependent binding, trapping dynamics and the time-course of IKr block to assess drug effects even at the steady-state.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Influence of genetic mutations to atria vulnerability to atrial fibrillation: An in-silico 3D human atria study

  • Belletti, Rebecca
  • Osca, Joaquín
  • Romero Pérez, Lucia|||0000-0003-4605-8630
  • Saiz Rodríguez, Francisco Javier|||0000-0002-9850-0825
[EN] Background and Objective: Personalized 3D computer models of atria have been extensively implemented in the last yearsas a tool to facilitate the understanding of the mechanisms underlying different forms of arrhythmia, such as atrial fibrillation (AF). Meanwhile, genetic mutations acting on potassium channel dynamics were demonstrated to induce fibrillatory episodes in asymptomatic patients. This research study aims at assessing the effects and the atrial susceptibility to AF of three gain-of-function mutations ¿ namely, KCNH2 T895M, KCNH2 T436M, and KCNE3-V17M ¿ associated with AF outbreaks, using highly detailed 3D atrial models with realistic wall thickness and heterogenous histological properties. Methods: The 3D atrial model was generated by reconstructing segmented anatomical structures from CT scans of an AF patient. Modified versions of the Courtemanche human atrial myocyte model were used to reproduce the electrophysiological activity of the WT and of the three mutant cells. Ectopic foci (EF) were simulated in sixteen locations across the atrial mesh using an S1-S2 protocol with two S2 basic cycle lengths (BCL) and eleven coupling intervals in order to induce arrhythmias. Results: The three genetic mutations at 3D level reduced the APD90. The KCNE3-V17M mutation provoked the highest shortening (55 % in RA and LA with respect to WT), followed by KCNH2 T895M (14 % in RA and 18 % LA with respect to WT)and KCNH2 T436M (7 % in RA and 9 % LA with respect to WT). The KCNE3-V17M mutation led to arrhythmia in 67 % of the cases simulated and in 94 % of ectopic foci considered, at S2 BCL equal to 100 ms. The KCNH2 T436M and KCNH2 T895M mutations increased the vulnerability to AF in a similar way, leading to arrhythmic episodes in 7 % of the simulated conditions, at S2 BCL set to 160 ms. Overall, 60 % of the arrhythmic events generated arise in the left atrium. Spiral waves, multiple rotors and disordered electrical pattern were elicited in the presence of the KCNE3-V17M mutation, exhibiting an instantaneous mean frequency of 7.6 Hz with a mean standard deviation of 1.12 Hz. The scroll waves induced in the presence of the KCNH2 T436M and KCNH2 T895M mutations showed steadiness and regularity with an instantaneous mean frequencies in the range of 4.9 ¿ 5.1 Hz and a mean standard deviation within 0.19 ¿ 0.53 Hz. Conclusions: The pro-arrhythmogenicity of the KCNE3-V17M, KCNH2 T895M and KCNH2 T436M mutations was studied and proved on personalized 3D cardiac models. The three genetic mutations were demonstrated to increase the predisposition of atrial tissue to the formation of AF-susceptible substrate in different ways based on their effects on electrophysiological properties of the atria., This work was supported by the European Union s Horizon 2020 research and innovation program under the Marie Skodowska-Curie gran agreement No. 766082 (MY-ATRIA project), by the Direccion General de Política Científica de la Generalitat Valenciana (PROMETEO/2020/043) and was partially funded by grant PID2022-140553OB-C41 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Experimentally validated modeling of dynamic drug-hERG channel interactions reproducing the binding mechanisms and its importance in action potential duration

  • Escobar-Ropero, Fernando|||0000-0001-7602-447X
  • Gomis-Tena Dolz, Julio|||0000-0002-1309-2368
  • Saiz Rodríguez, Francisco Javier|||0000-0002-9850-0825
  • Romero Pérez, Lucia|||0000-0003-4605-8630
  • Friis, Soren
  • Adly, Nouran
  • Brinkwirth, Nina
  • Klaerke, Dan A.
  • Stoelzle-Feix, Sonja
[EN] Background and Objective: Assessment of drug cardiotoxicity is critical in the development of new compounds and modeling of drug-binding dynamics to hERG can improve early cardiotoxicity assessment. We previously developed a methodology to generate Markovian models reproducing preferential state-dependent binding properties, trapping dynamics and the onset of IKr block using simple voltage clamp protocols. Here, we test this methodology with real IKr blockers and investigate the impact of drug dynamics on action potential prolongation. Methods: Experiments were performed on HEK cells stably transfected with hERG and using the Nanion SyncroPatch 384i. Three protocols, P-80, P0 and P40, were applied to obtain the experimental data from the drugs and the Markovian models were generated using our pipeline. The corresponding static models were also generated and a modified version of the O¿Hara-Rudy action potential model was used to simulate the action potential duration. Results: The experimental Hill plots and the onset of IKr block of ten compounds were obtained using our voltage clamp protocols and the models generated successfully mimicked these experimental data, unlike the CiPA dynamic models. Marked differences in APD prolongation were observed when drug effects were simulated using the dynamic models and the static models. Conclusions: These new dynamic models of ten well-known IKr blockers constitute a validation of our methodology to model dynamic drug¿hERG channel interactions and highlight the importance of state-dependent binding, trapping dynamics and the time-course of IKr block to assess drug effects even at the steady-state., This work was funded by the Spanish Ministerio de Ciencia, Innovacion y Universidades [grant "Formacion de Profesorado Universitario" FPU19/02200; grant PID2022-140553OB-C41 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU]; the European Union's Horizon 2020 research and innovation program [grant agreement No. 101016496 (SimCardioTest) ] and the Direccion General de Politica Cientifica de la Generalitat Valenciana [grant PROMETEO/2020/043]. SF, NA, NB and SS are employed by Nanion Technologies, the manufacturer of the SyncroPatch 384i used to obtain the experimental data of this manuscript. The dynamic models of the I Kr blockers have been generated in accordance with the technology protected by PCT/ES2023/070195 (patent pending).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A simulation study of the impact of drug-IKr binding mechanisms on biomarkers of proarrhythmic risk reveals a crucial role in reverse use-dependence of action potential duration and a marked influence on the vulnerable window

  • Gomis-Tena Dolz, Julio|||0000-0002-1309-2368
  • Escobar-Ropero, Fernando|||0000-0001-7602-447X
  • Romero Pérez, Lucia|||0000-0003-4605-8630
[EN] Background and objective In silico human models are being used more and more to predict the potential proarrhythmic risk of compounds. It has been shown that incorporation of the dynamics of drug-hERG channel interactions can have an important impact on the action potential duration (APD) at normal heart rates. Our aim is to investigate the relevance of drug dynamics on other important biomarkers of proarrhythmic risk. Methods We use the state-of-the-art mathematical models of the cardiac electrophysiological activity to simulate TRIaD biomarkers, namely Triangulation, Reverse use-dependency, electrical Instability of the action potential and Dispersion, together with the vulnerable window to unidirectional block. They were simulated in control conditions and in the presence of an extensive set of 114 in silico IKr blockers with different kinetics and affinities to conformational states of the channel and 10 well-known real IKr blockers at the concentration leading to a 25 % prolongation of the APD. Results Our results show that drug binding dynamics to hERG are crucial for the reverse use-dependence of APD, the slope of the APD restitution curve as a function of the root square of the cycle length ranging from 0 to 5.6 ms/ms (2.1 ms/ms in control conditions). The vulnerable window for unidirectional block and the transmural action potential duration dispersion markedly depended on the drug binding mechanisms and kinetics, although to a lesser extent. Virtual drugs led to increments of these two biomarkers from 25 % to 200 %. On the contrary, temporal instability and, beat-to-beat instability, are less dependent on the dynamics of drug binding. The results obtained with the models of real IKr blockers are in line with those obtained with the virtual drugs. Conclusions Our study highlights the importance of considering the drug binding mechanism, as well as the kinetics, to assess the effects of IKr blockers. Moreover, adoption of in silico models mimicking these characteristics would contribute to the improvement of the prediction of the proarrhythmic risk of new compounds., This work was funded by the Spanish Ministerio de Ciencia, Innovacion y Universidades [grant "Formacion de Profesorado Universitario" FPU19/02200; grant PID2022-140553OB-C41 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU] ; the European Union's Horizon 2020 research and innovation program [grant agreement No 101016496 (SimCardioTest) ] ; and the Agencia Valenciana de la Innovacio and by ERDF/EU (INNVA1/2024/60) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

In silico predictions of action potential propagation in doxorubicin cardiotoxicity: A parametric study using preclinical 3D magnetic resonance imaging-based fibrotic left ventricle models

  • Villar-Valero, Javier|||0009-0003-1889-0515
  • Trenor Gomis, Beatriz Ana|||0000-0001-9166-6112
  • Rodríguez Padilla, Jairo
  • Cedilnik, Nicolas
  • Ly, Buntheng
  • Gomez, Juan F.
  • Sermesant, Maxime
  • Pop, Mihaela
[EN] Doxorubicin (DOX) is a widely used chemotherapeutic agent, but its cardiotoxic effects, including diffuse myocardial fibrosis, increase the risk of dangerous arrhythmias. There is a critical need for non-invasive tools to predict DOX-related ventricular arrhythmias in early chronic stages following chemotherapy. A computational study was performed using experimental data from three pigs: one control and two at 9 weeks following DOX. Customized 3D left ventricular (LV) models were generated from late gadolinium-enhanced magnetic resonance imaging and electro-anatomical maps, integrating tissue structure, electrical properties (healthy/fibrosis) and fibre directions. Action potential (AP) wave propagation was simulated using a high-performance numerical solver. A virtual programmed stimulation protocol was applied in 96 simulations to assess arrhythmia inducibility, varying the parameters corresponding to excitability and conduction velocity in fibrotic zones. Arrhythmias were inducible only in DOX-treated cases. Reentrant wave genesis depended on: excitability, conduction velocity, fibrosis distribution and AP duration heterogeneity. In one scenario, AP heterogeneities and a ¿70% reduction in diffusion coefficient were required to induce reentry despite unchanged excitability in fibrosis. This study presents the first computational simulation of DOX-induced cardiotoxicity in a realistic 3D LV model using a highly efficient, automated Lattice¿Boltzmann approach. Our findings provide insights into arrhythmogenic mechanisms and may aid in developing strategies to prevent and treat DOX-related cardiotoxicity., European Comission Horizon 2020: Beatriz Trenor, 101016496; French Government: Maxime Sermesant, ANR-19-P3IA-0002; Canadian CIHR: Mihaela Pop, (PJT) 153212; Spanish Government: Javier VillarValero, MCIN/AEI/10.13039/501100011033; Spanish Government: Juan F Gomez, PID2022-136273OA-C33; Spanish Government: Beatriz Trenor, PID2022-140553OB-C41; Barcelona Supercomputing Center (BSC): Beatriz Trenor, IM-2021-1-0001 and IM-2021-3-0001.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Electromechanical computational modeling of heart failure provides extensive analysis of cardiac pathophysiological features

  • Casoni, Eva
  • Zingaro, Alberto
  • Gomez, Juan F.
  • Pozo, Jose M.
  • Gonzalez-Martin, Pablo
  • Vazquez, Mariano
  • Aguado-Sierra, Jazmin
  • Mora-Fenoll, María Teresa|||0000-0002-8069-2486
  • Trenor Gomis, Beatriz Ana|||0000-0001-9166-6112
[EN] This study applies a high-performance, fully coupled 3D-0D electromechanical model to simulate cardiac function across multiple scenarios of heart failure with reduced ejection fraction (HFrEF), including ventricular tachycardia post-myocardial infarction and acute hypertension. By integrating biomechanical deformation, electromechanical coupling, and hemodynamic feedback, the model provides a comprehensive analysis of different stages of heart failure. A physiologically detailed 3D-0D electromechanical model was used to simulate pressure-volume loops under different pathological conditions. The model incorporates hemodynamic coupling within an electromechanical framework to quantify left ventricular performance markers in virtual scenarios. Additionally, myocardial strains along the principal fiber direction were computed to assess systolic dysfunction and deformation. The simulations accurately predicted the hemodynamic impact of HFrEF according to their electrophysiological and mechanical properties. The computationally derived pressure-volume loops demonstrated a strong agreement with clinical findings, highlighting key features of HFrEF such as reduced stroke volume, impaired contractility, and decreased ejection fraction. Furthermore, scar-related conduction abnormalities were associated with an increased risk of ventricular tachycardia, with failing hearts exhibiting greater hemodynamic instability during arrhythmic episodes. The proposed computational framework provides a powerful tool for investigating HFrEF progression and electromechanical dysfunction. By accurately replicating pressure-volume loop characteristics and hemodynamic alterations commonly seen in clinical settings, this model enhances the understanding of HFrEF and may support the development of targeted therapeutic strategies., This work was partially funded by grant PID2022-136273OA-C33 and by grant PID2022-140553OB-C41 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU. EC, AZ, P.G-M MV, and JAS acknowledge the European Union - EIC Project No 190134524: "ELEM Virtual Heart Populations for Supercomputers" (ELVIS). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or EISMEA. Neither the European Union nor the granting authority can be held responsible for them. AZ, MV, and JAS acknowledge the European Union's Horizon Europe research and innovation program under grant agreement No 101136728 (VITAL). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or EISMEA. Neither the European Union nor the granting authority can be held responsible for them. JMP has received funding from the European Union's Horizon 2020 research and innovation program under Marie Sk & lstrok;odowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia's Agency for Business Competitiveness (ACCIo)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Insights from electromechanical simulations to assess omecamtiv mecarbil efficacy in heart failure

  • Mora-Fenoll, María Teresa|||0000-0002-8069-2486
  • Saiz Rodríguez, Francisco Javier|||0000-0002-9850-0825
  • Trenor Gomis, Beatriz Ana|||0000-0001-9166-6112
  • van Herck, Ilse
  • Daversin-Catty, Cécile
  • Finsberg, Henrik
  • Llopis-Lorente, Jordi
  • Arevalo, Hermenegild
  • Wall, Samuel
[EN] Heart failure is a cardiac pathology characterized by causing myocardial dysfunction. The need to improve current pharmacotherapy for patients with heart failure has encouraged the development of more promising compounds. Currently, the amount of experimentation required during the early phases of drug development to assess safety and efficacy is costly, but computer simulations can help accelerate the process. In the present study, we performed computer simulations to investigate the electromechanical effects of the sarcomeric drug omecamtiv mecarbil on cardiac tissue. We used a cellular human electromechanical model to develop a concentration-dependent numerical model for the pharmacological compound based on previous experimental evidence. It was then implemented on a ventricular slab to extrapolate cellular activity to myocardial tissue scale, and heart failure with reduced ejection fraction conditions was reproduced. In silico results reveal that omecamtiv mecarbil can correct the depressed active force developed by failing myocytes and make the slab contract to the same extent as in healthy conditions. However, additional changes involving contraction times and diastolic function, measured as the time to active tension peak and baseline slab stretch, respectively, can compromise the pumping capacity of the heart. After exploring drug effects at different heart rates, results show that elevated stimulation frequencies (2 Hz), together with overdoses (omecamtiv mecarbil > 0.8 mu m), are the main factors reducing fractional shortening and leading to loss of function. We demonstrate that electromechanical simulation results can provide a better understanding of the mechanism of action of a drug and facilitate the redirection of future investigations.Key points A new pipeline to assess the efficacy of inotropic drugs based on computational electromechanical models is described. Omecamtiv mecarbil increases developed force in failing cardiac tissue. Undesirable effects on diastolic function and contraction duration override the positive effects. Fast heart rates and elevated omecamtiv mecarbil doses aggravate cardiac dysfunction., This work was partially funded by European Union's Horizon 2020 Framework Programme (SimCardioTest project, grant agreement 101 016 496), and by grant PID2022-140553OB-C41 funded by MICIU/AEI/10.13039/501 100 011 033 and by ERDF/EU. Funding for open access charge: CRUE-Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Integration of electrophysiological and mechanical biomarkers in cardiac risk assessment models

  • Priego-Saiz, Lucía
  • Llopis-Lorente, Jordi
  • Finsberg, Henrik
  • Daversin-Catty, Cécile
  • Van Herck, Ilsbeth
  • Wall, Samuel
  • Arevalo, Hermenegild
  • Mora-Fenoll, María Teresa|||0000-0002-8069-2486
  • Saiz Rodríguez, Francisco Javier|||0000-0002-9850-0825
  • Trenor Gomis, Beatriz Ana|||0000-0001-9166-6112
[EN] Background and Objective: Cardiac drug safety assessment is essential to detect molecules with potential adverse effects, particularly those increasing the risk of arrhythmias such as Torsade de Pointes (TdP). The challenge lies in achieving early predictions with minimal experimental studies while maintaining high sensitivity and specificity. Traditional approaches rely primarily on electrophysiological (EP) biomarkers; however, mechanical effects of drugs on cardiac contractility remain underexplored. This study aims to integrate electrophysiological and mechanical biomarkers to improve cardiac risk assessment models. Methods: The present study investigated the integration of electrophysiological and mechanical biomarkers using a cellular and three-dimensional in silico population approach. We evaluated the effects on different EP and mechanical relevant biomarkers to assess both, the proarrhythmic and inotropic risks of 39 compounds, including CiPA compounds and calcium channel blockers (CCBs). Classification models were developed using EP biomarkers alone and in combination with mechanical biomarkers to evaluate their predictive capabilities. Results: Classification models based solely on EP biomarkers demonstrated robust prediction on CiPA torsadogenic risk. The inclusion of mechanical biomarkers did not enhance classification accuracy for TdP risk. However, mechanical metrics revealed significant contractile changes induced by CCBs and other negative inotropic compounds, such as mavacamten. Drugs induced a range of fractional shortening values, correlated with ejection fraction variations, highlighting clinically relevant contractile effects. Conclusions: EP-based assessments remain reliable for predicting torsadogenic risk, but mechanical biomarkers provide crucial insights into drug-induced cardiac contractile effects. Future studies should focus on increasing experimental data availability and incorporating more complex cardiac geometries to enhance translational applicability of in silico models in comprehensive drug safety evaluation., Cellular simulations were performed on resources provided by Rigel cluster from the Universitat Politecnica de Valencia. Tissue simulations were performed on resources provided by Sigma2-the National Infra-structure for High Performance Computing and Data Storage in Norway. This work was partially funded by European Union's Horizon 2020 Framework Programme (SimCardioTest project, grant agreement 101016496) , and by grant PID2022-140553OB-C41 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU. Funding for open access charge: CRUE-Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

In Silico Study of Ventricular Arrhythmias in Structurally and Functionally Remodeled Myocardium

  • Villar-Valero, Javier|||0009-0003-1889-0515
[ES] Las arritmias ventriculares continúan siendo una de las principales causas de muerte súbita cardíaca en corazones estructuralmente remodelados. A pesar de los avances en imagen y electrofisiología, la estratificación clínica del riesgo y los criterios de éxito de los procedimientos siguen basándose en marcadores globales y en pruebas de inducibilidad dependientes del protocolo, que pueden no reflejar la complejidad real del sustrato arrítmico. Esta tesis aborda la arritmogénesis ventricular como un fenómeno dependiente del sustrato que emerge de la interacción entre la estructura miocárdica, la heterogeneidad espacial electrofisiológica y factores moduladores dinámicos. La hipótesis central plantea que la reentrada aparece cuando el remodelado anatómico genera vías permisivas de conducción lenta y el acoplamiento local entre activación y recuperación permite interacciones frente-cola de onda capaces de explotar dichas vías. El objetivo principal es desarrollar y aplicar modelos computacionales mecanísticamente fundamentados que permitan identificar los determinantes estructurales y funcionales de la vulnerabilidad arrítmica ventricular. Para ello, se construyeron modelos ventriculares específicos de paciente y sujeto a partir de resonancia magnética con realce tardío de gadolinio, incorporando representaciones detalladas de cicatriz y fibrosis. El comportamiento electrofisiológico se simuló mediante mallas volumétricas anatómicamente detalladas y una formulación monodominio acoplada a modelos celulares ventriculares biofísicamente detallados, permitiendo el análisis mecanístico de la activación y la repolarización en sustratos remodelados. Se incorporó la modulación autonómica para evaluar los efectos simpáticos mediados por el ganglio estrellado sobre la repolarización y la vulnerabilidad arrítmica. La propensión a la arritmia se cuantificó mediante protocolos de estimulación y mediante el Reentry Vulnerability Index (RVI). Asimismo, se mejoró la escalabilidad computacional mediante la implementación de un esquema acelerado en GPU basado en el método de lattice Boltzmann acoplado a un modelo simplificado y calibrable de potencial de acción. Los resultados demuestran que la organización espacial de la cicatriz y la fibrosis, en particular la presencia de corredores de conducción dentro de tejido heterogéneo, condiciona de forma decisiva el inicio y mantenimiento de reentradas sostenidas. Además, la modulación simpática puede modificar significativamente los gradientes de repolarización y los patrones de vulnerabilidad incluso sin cambios en la inducibilidad clásica, lo que respalda el RVI como marcador basado en el sustrato capaz de capturar susceptibilidad latente. En el remodelado difuso no isquémico, los patrones específicos de fibrosis y la dispersión electrofisiológica determinan la dinámica de la reentrada, subrayando la relevancia de la caracterización estructural personalizada. En conjunto, esta tesis propone una visión estructural-funcional integrada de la arritmogénesis ventricular, destacando que el riesgo arrítmico depende no solo del remodelado anatómico, sino también de factores electrofisiológicos dinámicos y moduladores. Mediante el avance de estrategias mecanísticas y computacionales específicas de paciente, este trabajo contribuye hacia una evaluación más fundamentada fisiológicamente de la vulnerabilidad arrítmica ventricular., This work was supported by Grant PRE2020-091849 [MCIN/AEI/10.13039/50 1100011033] and “ESF Investing in your future”; Grant PID2019-104356RB-C41 [MCIN/AEI/10.13039/501100011033]; PID2022-136273OA-C33 and PID2022- 140553OB-C41 [MICIU/AEI/10.13039/501100011033 and by ERDF/EU]; Barcelona Supercomputing Center [IM-2021-1-0001, IM-2021-3-0001, IM-2024- 1-0010 and IM-2024-2-0015]; Oracle Cloud credits and related resources by Oracle for Research; and Teknon projects European Comission Horizon 2020: Beatriz Trenor, 101016496; French Government: Maxime Sermesant, ANR-19-P3IA-0002; Canadian CIHR: Mihaela Pop, (PJT) 153212; Spanish Government: Javier VillarValero, MCIN/AEI/10.1303 9/501100011033; Spanish Government: Juan F Gomez, PID2022-136273OAC33; Spanish Government: Beatriz Trenor, PID2022-140553OB-C41; Barcelona Supercomputing Center (BSC): Beatriz Trenor, IM-2021-1-0001 and IM-2021-3-0001.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Computational modeling of post-myocardial infarction arrhythmias: Insights and predictions

  • Villar-Valero, Javier|||0009-0003-1889-0515
  • Trenor Gomis, Beatriz Ana|||0000-0001-9166-6112
  • Gomez, Juan F.
  • Soto-Iglesias, David
  • Penela, Diego
  • Berruezo, Antonio
[EN] Background: Ventricular arrhythmias are a significant risk for patients who have suffered a myocardial infarction, with cardiac scar remodeling playing a critical role in arrhythmia development. Understanding the structural and electrical properties of the scar and its surrounding tissue is essential for assessing arrhythmia risk. Objective: This study aimed to investigate the role of scar anatomy and border zone properties in predicting ventricular arrhythmias, using patient-specific three-dimensional models derived from medical imaging. Methods: The study involved 29 post-myocardial infarction patients. Comprehensive segmentation of the ventricles was performed to generate 3D models incorporating the scar, its core, and the border zone. Arrhythmia inducibility was assessed through in silico simulations using a clinical early-pacing protocol. Different configurations of the border zone were tested, varying fibroblast density and ionic current remodeling. Results: Reentry was induced in 16 of the 29 virtual patients, 13 of whom also experienced clinical reentry. Conversely, the 13 virtual patients in whom reentry was not induced also did not show reentry clinically. The simulations demonstrated that varying fibrosis density within the same scar structure can lead to different arrhythmic scenarios. Key quantified parameters related to scar anatomy, including the extent of the border zone and conduction channels, were identified as strong predictors of arrhythmia risk. Conclusion: This study highlights the importance of scar anatomy in post-infarction arrhythmias and provides a novel approach to predicting arrhythmic risk. The findings support the use of patient-specific scar remodeling data for improving clinical risk assessments and guiding therapy to prevent future arrhythmias., This work was supported by Grant PRE2020-091849 [MCIN/AEI/ 10.13039/501100011033] and ESF Investing in your future ; Grant PID2019-104356RB-C41 MCIN/AEI/ 10.13039/ 501100011033; PID2022-136273OA-C33 and PID2022-140553OB-C41 [MICIU/AEI/ 10.13039/501100011033 and by ERDF/EU]; Barcelona Supercomputing Center, Spain [IM-2021-1-0001 and IM-2021-3-0001]; Oracle Cloud credits and related resources by Oracle for Research; and Teknon projects. Funding for open access charge: CRUE-Universitat Politècnica de València.